Shilajit Extract: Examining Biomedical Applications—A Systematic Review Protocol
Background: Shilajit, a natural mineral exudate utilized for centuries in traditional Ayurvedic and Eastern European medicine, is regarded as a traditional adaptogenic substance and rejuvenator. This systematic review synthesizes contemporary scientific evidence regarding the biomedical applications of Shilajit extract, critically evaluating its pharmacological properties and therapeutic potential. Methods: A systematic search was performed across PubMed, Scopus, Web of Science, and the Cochrane Library for peer-reviewed literature published between 1951 and 2026. Studies were screened against rigorous eligibility criteria, and methodological quality was appraised using the Cochrane Risk of Bias 2.0 and SYRCLE tools. Results: Studies were included in the final analysis. Characterized by high concentrations of fulvic acid and dibenzo-α-pyrones, Shilajit exhibits antioxidant activity, anti-inflammatory, neuroprotective, and adaptogenic activities. Preclinical data demonstrate dose-dependent cytotoxicity against multiple cancer cell lines via apoptosis induction. Furthermore, evidence suggests its efficacy in enhancing muscular strength, improving reproductive function, and mitigating protein aggregation in neurodegenerative contexts. Conclusions: Shilajit possesses significant biomedical potential that aligns with its traditional applications. However, clinical integration requires addressing standardization challenges, implementing stringent quality control to mitigate heavy metal risks, and conducting large-scale human trials to definitively establish safety and efficacy profiles.
Authors
- Svіtlana Zahorodnia (ORCID: https://orcid.org/0000-0002-0892-772X)
- Lucía Margarita Valenzuela-Salas (ORCID: https://orcid.org/0000-0002-2226-0431)
- Nenad Janković (ORCID: https://orcid.org/0000-0002-2295-9410)
- Ricardo Valdez (ORCID: https://orcid.org/0000-0001-8196-0027)
- Graciela Lizeth Pérez-González (ORCID: https://orcid.org/0000-0003-0721-678X)
- Nodari Rizun (ORCID: https://orcid.org/0000-0002-1688-5881)
- Luis Jesús Villarreal-Gómez (ORCID: https://orcid.org/0000-0002-4666-1408)
- Angélica Garzón-Fontecha (ORCID: https://orcid.org/0000-0001-9009-9734)
- Carlos Rodríguez-Escobar
Institutions
- University of Kragujevac (RS)
- Universidad Autónoma de Baja California (MX)
- Tecnológico Nacional de México (MX)
- Instituto Tecnológico de Tijuana (MX)
- Danylo Zabolotny Institute of Microbiology and Virology (UA)
- Institute for Information Technologies Kragujevac (RS)
Publication Details
- Journal
- Pharmaceuticals
- Published
- 2026-11-13
- DOI
- https://doi.org/10.3390/ph19111802
- Primary Topic
- Humic Substances and Bio-Organic Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00